Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
ZESTORETIC
Generic name / active ingredient
lisinopril and hydrochlorothiazide
Dosage-form class
Lisinopril/hydrochlorothiazide fixed two-ingredient uncoated oral tablets: 10/12.5 mg, 20/12.5 mg and 20/25 mg; each pair states the two ingredients in one tablet
Route
Oral
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • Check the active ingredients on every pack. ZESTRIL is lisinopril alone and MICROZIDE is hydrochlorothiazide alone; HYZAAR, DIOVAN HCT, AVALIDE and EXFORGE HCT also contain hydrochlorothiazide. If they appear together, do not remove or add a pack yourself; a pharmacist or prescriber must review the complete prescriptions.
  • ENTRESTO contains sacubitril/valsartan. The current ZESTORETIC label identifies products containing a neprilysin inhibitor as a special contraindication boundary and states a 36-hour restriction around switching an ACE inhibitor. The site does not use that statement to arrange an individual's stopping or switching; contact the prescriber or pharmacist promptly for review.
  • Swelling of the face, lips, tongue or throat, or difficulty swallowing or breathing, may be angioedema and requires local emergency services immediately. Do not wait for a website assessment.
  • Dizziness, fainting, marked weakness, thirst, clearly reduced urine, persistent vomiting or diarrhoea, muscle weakness or cramps, or an abnormal heartbeat may accompany changes in blood pressure, fluid balance, kidney function or electrolytes. Use local emergency services for severe or sudden symptoms or altered consciousness.

Reviewed presentation examples — compare every field

  • Lisinopril 10 mg plus hydrochlorothiazide 12.5 mg per tablet; 90-tablet bottleNDC 52427-435-90
  • Lisinopril 20 mg plus hydrochlorothiazide 12.5 mg per tablet; 90-tablet bottleNDC 52427-436-90
  • Lisinopril 20 mg plus hydrochlorothiazide 25 mg per tablet; 90-tablet bottleNDC 52427-437-90

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image